They are commercially useful for the duration of the patent (20 year starting point). Keep in mind that a few years are eaten up during your clinical trials, but you also can get patent extension terms. Overall, you get about ~15 years of good earnings from them. But with new innovations, the timeline will likely reduce in the future as successor treatments are created, so there may be less value even before patent expiry.
